chr5-128083972-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The ENST00000262461.7(SLC12A2):āc.18G>Cā(p.Thr6=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000317 in 1,239,502 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.00034 ( 1 hom., cov: 32)
Exomes š: 0.00031 ( 5 hom. )
Consequence
SLC12A2
ENST00000262461.7 synonymous
ENST00000262461.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.343
Genes affected
SLC12A2 (HGNC:10911): (solute carrier family 12 member 2) The protein encoded by this gene mediates sodium and chloride transport and reabsorption. The encoded protein is a membrane protein and is important in maintaining proper ionic balance and cell volume. This protein is phosphorylated in response to DNA damage. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 5-128083972-G-C is Benign according to our data. Variant chr5-128083972-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 2146972.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 5 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC12A2 | NM_001046.3 | c.18G>C | p.Thr6= | synonymous_variant | 1/27 | ENST00000262461.7 | NP_001037.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC12A2 | ENST00000262461.7 | c.18G>C | p.Thr6= | synonymous_variant | 1/27 | 1 | NM_001046.3 | ENSP00000262461 | P4 | |
SLC12A2 | ENST00000343225.4 | c.18G>C | p.Thr6= | synonymous_variant | 1/26 | 1 | ENSP00000340878 | A2 | ||
SLC12A2 | ENST00000509205.5 | c.18G>C | p.Thr6= | synonymous_variant, NMD_transcript_variant | 1/27 | 1 | ENSP00000427109 | |||
SLC12A2 | ENST00000628403.2 | c.18G>C | p.Thr6= | synonymous_variant | 1/26 | 5 | ENSP00000486323 |
Frequencies
GnomAD3 genomes AF: 0.000337 AC: 51AN: 151556Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
51
AN:
151556
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000314 AC: 342AN: 1087840Hom.: 5 Cov.: 30 AF XY: 0.000358 AC XY: 185AN XY: 517424
GnomAD4 exome
AF:
AC:
342
AN:
1087840
Hom.:
Cov.:
30
AF XY:
AC XY:
185
AN XY:
517424
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000336 AC: 51AN: 151662Hom.: 1 Cov.: 32 AF XY: 0.000513 AC XY: 38AN XY: 74120
GnomAD4 genome
AF:
AC:
51
AN:
151662
Hom.:
Cov.:
32
AF XY:
AC XY:
38
AN XY:
74120
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
12
AN:
3348
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 26, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2023 | SLC12A2: BP4, BP7 - |
SLC12A2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 02, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at